Moderna Drops 11%, ImmunityBio Slide Wakes Biotech Rout
Biotech shares retreat as Moderna slides 11% and ImmunityBio falls, with Sarepta also sinking amid a broad market rot...
Learn which low fee index funds beat the market in 2024 and how they can fit into a retirement strategy. This guide highlights top performers and practical steps for investors.
28,527 articlesBiotech shares retreat as Moderna slides 11% and ImmunityBio falls, with Sarepta also sinking amid a broad market rot...
Software stocks are rebounding as growth signals improve and enterprise demand remains resilient. Analysts warn that ...
As AI momentum pauses, three AI-driven tech stocks worth buying the dip emerge with signs of improving fundamentals a...
Oil climbs to the $100 level as tech stocks retreat, pushing the Nasdaq Composite lower. Investors weigh energy price...
Institutional activity in Bitcoin ETFs is more nuanced than daily inflows suggest. This piece examines how market mak...
Extra Space Storage wrapped up Q4 2025 with steady occupancy and disciplined capital management. This article breaks ...
Cannabis stocks remain volatile and Canopy Growth sits at a crossroads in 2026. This article explains why many invest...
B&G Foods' Q1 2026 earnings set the stage for a cautious yet encouraging year. This guide breaks down the drivers, ri...
Bank of America will keep funding housing affordability efforts, surpassing its initial goal and making the Community...
Walmart CFO cites a drop in average gas fills as a sign of consumer stress, highlighting how higher fuel costs are sh...
AI is reshaping how we power and cool data centers, not just how we drive cars. This article highlights an under-the-...
The February CPI data show inflation stayed above the FED's 2% goal even as monthly gains cooled, keeping markets foc...